Related Experiment Video
Updated: Mar 26, 2026

Detrusor Underactivity Model in Rats by Conus Medullaris Transection
Published on: August 28, 2020
Effect of Scopolamine Patch Use on Postoperative Voiding Function After Transobturator Slings.
Sybil G Dessie1, Michele R Hacker, Costas Apostolis
1From the *Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center; †Department of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School, Boston; and ‡Department of Obstetrics and Gynecology, Mount Auburn Hospital, Cambridge, MA.
Transdermal scopolamine (TDS) patches used for nausea prevention after transobturator tape surgery significantly increase the risk of voiding trial failure. This finding highlights potential complications of TDS in urogynecological procedures.
Area of Science:
- Urogynecology
- Surgical Outcomes
- Pharmacology
Background:
- Postoperative nausea and vomiting (PONV) is a common complication after surgical procedures.
- Transobturator tape (TOT) sling procedures are frequently performed for stress urinary incontinence.
- Prophylaxis for PONV may impact other postoperative outcomes.
Purpose of the Study:
- To investigate the effect of preoperative transdermal scopolamine (TDS) patch use on voiding trial success after TOT sling surgery.
- To determine if TDS for PONV prophylaxis influences postoperative urinary function recovery.
Main Methods:
- Retrospective cohort study design.
- Inclusion of adult women undergoing TOT sling procedures without concomitant surgeries.
- Comparison of voiding trial failure rates between women who received a preoperative TDS patch and those who did not.
Main Results:
- A significantly higher proportion of women using TDS patches (54.3%) failed their voiding trial compared to the non-TDS group (7.1%).
- TDS patch use was associated with a 13.8-fold increased risk of voiding trial failure.
- Factors like prior incontinence surgery, older age, and higher BMI amplified the association.
Conclusions:
- Preoperative TDS patch use for PONV prophylaxis may negatively impact voiding trial success post-TOT sling.
- Clinicians should consider the potential for impaired bladder function when prescribing TDS in this patient population.
Related Concept Videos
Imaging Studies VI: Voiding Cystourethrography and Cystography
Urodynamic Studies: Uroflowmetry
Imaging Studies II: Ultrasonography

